Legacy Pharma Inc.
Records under this name other than the patents Legacy Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 4 of 4 · Back to Legacy Pharma Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,859,576 | Method of Treating Thermoregulatory Dysfunction with Paroxetine Term ended Term ended Aug 4, 2026 · Medium confidence | Term ended | Term ended Aug 4, 2026 | Medium confidence |
| US 8,946,251 | Method of Treating Thermoregulatory Dysfunction with Paroxetine Term ended Term ended Aug 4, 2026 · Medium confidence | Term ended | Term ended Aug 4, 2026 | Medium confidence |
| US 9,393,237 | Method of Treating Thermoregulatory Dysfunction with Paroxetine Term ended Term ended Aug 4, 2026 · Medium confidence | Term ended | Term ended Aug 4, 2026 | Medium confidence |
| US 6,900,327 | 4-Phenylpiperidine Compounds Term ended Ended no later than Jun 10, 2017 · Low confidence | Term ended | Ended no later than Jun 10, 2017 | Low confidence |